XML 90 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisitions and divestitures - Summary of Total Consideration for Teneobio Inc (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Contingent consideration   $ 0 $ 0 $ 309
Goodwill $ 15,529 $ 18,629 15,529 $ 14,890
Teneobio        
Business Acquisition [Line Items]        
Cash purchase price 993      
Contingent consideration 299      
Total consideration 1,292      
Cash and cash equivalents 100   100  
Goodwill 273   273  
Other assets, net 16   16  
Deferred tax liability (244)   (244)  
Total assets acquired, net 1,292   1,292  
Teneobio | R & D Technology rights        
Business Acquisition [Line Items]        
Finite-lived intangible assets 115   115  
Teneobio | Licensing rights        
Business Acquisition [Line Items]        
Finite-lived intangible assets 41   41  
Teneobio | IPR&D        
Business Acquisition [Line Items]        
IPR&D $ 991   $ 991